Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Angiodynamics Inc Issues FY 2014 Revenue Guidance In Line With Analysts' Estimates-Conference Call


Wednesday, 14 Aug 2013 05:00pm EDT 

Angiodynamics Inc announced that for fiscal 2014, it expects modest revenue growth of basically 1% to 3%. The Company reported revenue of $342.03 million for fiscal 2013. According to I/B/E/S estimates, analysts were expecting the Company to report revenue of $348.66 million for fiscal 2014. 

Company Quote

16.86
 --
4 May 2015